Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Research

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis

Marcello Tonelli, Anita Lloyd, Fiona Clement, Jon Conly, Don Husereau, Brenda Hemmelgarn, Scott Klarenbach, Finlay A. McAlister, Natasha Wiebe and Braden Manns
CMAJ November 08, 2011 183 (16) E1189-E1202; DOI: https://doi.org/10.1503/cmaj.101280
Marcello Tonelli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mtonelli-admin@med.ualberta.ca
Anita Lloyd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fiona Clement
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jon Conly
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Don Husereau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brenda Hemmelgarn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Klarenbach
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Finlay A. McAlister
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natasha Wiebe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Braden Manns
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 183 no. 16 E1189-E1202
DOI 
https://doi.org/10.1503/cmaj.101280
PubMed 
21989464
History 
  • Published online November 7, 2011.

Article Versions

  • Latest version (October 11, 2011 - 08:20).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2011 Canadian Medical Association or its licensors

Author Information

  1. Marcello Tonelli, MD SM⇓,
  2. Anita Lloyd, MSc,
  3. Fiona Clement, PhD,
  4. Jon Conly, BA,
  5. Don Husereau, BScPharm MSc,
  6. Brenda Hemmelgarn, PhD MD,
  7. Scott Klarenbach, MD MSc,
  8. Finlay A. McAlister, MD MSc,
  9. Natasha Wiebe, MMath PStat,
  10. Braden Manns, MD MSc
  11. for the Alberta Kidney Disease Network
  1. Department of Medicine (Tonelli, Lloyd, McAlister), University of Alberta, Edmonton, Alta.; the Department of Community Health Sciences (Clement, Hemmelgarn, Manns), University of Calgary, Calgary, Alta.; the Alberta Kidney Disease Network (Tonelli, Lloyd, Conly, Hemmelgarn, Klarenbach, Wiebe, Manns), Calgary/Edmonton, Alta.; the Department of Epidemiology and Community Medicine (Husereau, Klarenbach, Wiebe), University of Ottawa, Ottawa, Ont.; and the Department of Medicine (Hemmelgarn, Manns), University of Calgary, Calgary, Alta. The complete list of members of the Alberta Kidney Disease Network is available at www.akdn.info
  1. Correspondence to:
    Dr. Marcello Tonelli, mtonelli-admin{at}med.ualberta.ca
View Full Text

Statistics from Altmetric.com

Usage statistics: October 2011 to February 2023

AbstractFullPdf
Oct 2011133110864
Nov 20111694517632
Dec 2011701291439
Jan 2012477213259
Feb 2012362244215
Mar 2012380213202
Apr 2012334119129
May 2012243120126
Jun 2012244106103
Jul 20121395591
Aug 20122018789
Sep 20122135879
Oct 2012295160159
Nov 20122719698
Dec 20122204247
Jan 201330110949
Feb 20131773971
Mar 20131873963
Apr 20131924590
May 20131634950
Jun 20131493258
Jul 2013823958
Aug 2013874957
Sep 20131435471
Oct 2013163272157
Nov 2013214294247
Dec 2013924040
Jan 20141154563
Feb 20141043046
Mar 20141635065
Apr 20141693556
May 20141122235
Jun 2014931426
Jul 2014961923
Aug 20141072326
Sep 20141173427
Oct 2014145173155
Nov 2014114155143
Dec 201479198174
Jan 20151612069
Feb 20152192827
Mar 20151192414
Apr 20151682018
May 20151251819
Jun 2015116219
Jul 2015111812
Aug 2015148249
Sep 2015161168
Oct 2015113194164
Nov 2015144129106
Dec 20151068754
Jan 20161053120
Feb 20161172319
Mar 20161562037
Apr 2016882411
May 20161003113
Jun 201669199
Jul 2016702315
Aug 2016651914
Sep 20161012423
Oct 20161023313
Nov 2016692310
Dec 2016703821
Jan 20175716117
Feb 20175815017
Mar 20176419020
Apr 20176921216
May 20177122917
Jun 20173118418
Jul 20174413412
Aug 20174616517
Sep 20175319212
Oct 20176019214
Nov 20174414313
Dec 201710254
Jan 20189444
Feb 2018136012
Mar 201875511
Apr 201873810
May 201812709
Jun 20188415
Jul 2018124511
Aug 2018114911
Sep 20188638
Oct 20181013910
Nov 20181015017
Dec 201891608
Jan 20191110924
Feb 201917938
Mar 2019185921
Apr 201920449
May 2019114012
Jun 2019162011
Jul 201910217
Aug 201910198
Sep 201964014
Oct 201994726
Nov 2019375913
Dec 2019234614
Jan 20201212619
Feb 2020193714
Mar 2020193322
Apr 2020165721
May 2020137912
Jun 2020131914
Jul 202015378
Aug 2020195318
Sep 2020218159
Oct 2020349736
Nov 2020214525
Dec 2020188315
Jan 2021174731
Feb 202111468
Mar 2021205531
Apr 2021124810
May 2021205418
Jun 2021206921
Jul 2021124232
Aug 2021175626
Sep 2021136043
Oct 2021116437
Nov 2021166049
Dec 2021114714
Jan 2022173521
Feb 2022164819
Mar 2022328456
Apr 2022233523
May 2022225165
Jun 2022185238
Jul 2022174644
Aug 202295034
Sep 2022125940
Oct 2022313827
Nov 2022196334
Dec 202266024
Jan 2023168522
Feb 2023342

Cited By...

  • 74 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 183 (16)
CMAJ
Vol. 183, Issue 16
8 Nov 2011
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis
Marcello Tonelli, Anita Lloyd, Fiona Clement, Jon Conly, Don Husereau, Brenda Hemmelgarn, Scott Klarenbach, Finlay A. McAlister, Natasha Wiebe, Braden Manns
CMAJ Nov 2011, 183 (16) E1189-E1202; DOI: 10.1503/cmaj.101280

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis
Marcello Tonelli, Anita Lloyd, Fiona Clement, Jon Conly, Don Husereau, Brenda Hemmelgarn, Scott Klarenbach, Finlay A. McAlister, Natasha Wiebe, Braden Manns
CMAJ Nov 2011, 183 (16) E1189-E1202; DOI: 10.1503/cmaj.101280
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines: A Cost-Effectiveness Analysis
  • Acute myocardial infarction and influenza: a meta-analysis of case-control studies
  • Statins and Cardiovascular Primary Prevention in CKD: A Meta-Analysis
  • Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
  • Low-Risk Diet and Lifestyle Habits in the Primary Prevention of Myocardial Infarction in Men: A Population-Based Prospective Cohort Study
  • The Role of Statins in Diabetes Treatment
  • Drug Repurposing Screen Reveals FDA-Approved Inhibitors of Human HMG-CoA Reductase and Isoprenoid Synthesis That Block Cryptosporidium parvum Growth
  • Statins for primary prevention
  • Statins for primary prevention
  • The efficacy and cost-effectiveness of statins in low-risk patients
  • Google Scholar

More in this TOC Section

  • Hospital factors associated with maternal and neonatal outcomes of deliveries to patients with a previous cesarean delivery: an ecological study
  • Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidity: a cohort study
  • Association between virtual primary care and emergency department use during the first year of the COVID-19 pandemic in Ontario, Canada
Show more Research

Similar Articles

Collections

  • Topics
    • Drugs: cardiovascular system

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire